CRD-BP/IMP1 expression characterizes cord blood CD34+ stem cells and affects c-myc and IGF-II expression in MCF-7 cancer cells - sprookjes - yvandenbroek - TriplyDB

CRD-BP/IMP1 expression characterizes cord blood CD34+ stem cells and affects c-myc and IGF-II expression in MCF-7 cancer cells

CRD-BP/IMP1 expression characterizes cord blood CD34+ stem cells and affects c-myc and IGF-II expression in MCF-7 cancer cells

http://www.wikidata.org/entity/Q28239956

about

MicroRNA let-7: an emerging next-generation cancer therapeutic Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression CRD-BP shields c-myc and MDR-1 RNA from endonucleolytic attack by a mammalian endoribonuclease Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism Regulation of local expression of cell adhesion and motility-related mRNAs in breast cancer cells by IMP1/ZBP1 TTS mapping: integrative WEB tool for analysis of triplex formation target DNA sequences, G-quadruplets and non-protein coding regulatory DNA elements in the human genome Assessing specific oligonucleotides and small molecule antibiotics for the ability to inhibit the CRD-BP-CD44 RNA interaction.Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival Humoral autoimmune responses to insulin-like growth factor II mRNA-binding proteins IMP1 and p62/IMP2 in ovarian cancer.Oncogenic mechanisms of Lin28 in breast cancer: new functions and therapeutic opportunities.The imprinted H19 lncRNA antagonizes let-7 microRNAs.Two isoforms of the mRNA binding protein IGF2BP2 are generated by alternative translational initiation.Epigenetic subclassification of meningiomas based on genome-wide DNA methylation analyses.Molecular insights into the coding region determinant-binding protein-RNA interaction through site-directed mutagenesis in the heterogeneous nuclear ribonucleoprotein-K-homology domains.Transcriptional Regulation of CRD-BP by c-myc: Implications for c-myc Functions Two Isoforms of the RNA Binding Protein, Coding Region Determinant-binding Protein (CRD-BP/IGF2BP1), Are Expressed in Breast Epithelium and Support Clonogenic Growth of Breast Tumor Cells Regulation of let-7 and its target oncogenes (Review)Characterizing the Coding Region Determinant-Binding Protein (CRD-BP)-Microphthalmia-associated Transcription Factor (MITF) mRNA interaction.Feedback regulation between zipcode binding protein 1 and beta-catenin mRNAs in breast cancer cells Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?Blocking beta-catenin binding to the ZBP1 promoter represses ZBP1 expression, leading to increased proliferation and migration of metastatic breast-cancer cells.MicroRNA-494 suppresses cell proliferation and induces senescence in A549 lung cancer cells.Modulation of IGF2BP1 by long non-coding RNA HCG11 suppresses apoptosis of hepatocellular carcinoma cells via MAPK signaling transduction.Regulation of Stem Cell Self-Renewal and Oncogenesis by RNA-Binding Proteins.PKCδ-induced PU.1 phosphorylation promotes hematopoietic stem cell differentiation to dendritic cells.Tumor-suppressive lipoxygenases inhibit the expression of c-myc mRNA coding region determinant-binding protein/insulin-like growth factor II mRNA-binding protein 1 in human prostate carcinoma PC-3 cells.Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) promotes lung tumorigenesis via attenuating p53 stability.SRC increases MYC mRNA expression in ER+ breast cancer via mRNA stabilization and inhibition of p53 function.IGF2BP1 overexpression causes fetal-like hemoglobin expression patterns in cultured human adult erythroblasts.Let-7a regulation of insulin-like growth factors in breast cancer.Role of family microRNA in breast cancer Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is an important protumorigenic factor in hepatocellular carcinoma

P2860

Q24644251-5C2591DF-2005-4482-8849-ACD4FAA44364 Q24653755-48DED904-B19E-47A0-87E4-F8666A6CA138 Q24684080-EE8D3003-06F7-4DF8-A42C-D4887E96A233 Q26774456-A0206AD9-67C9-482C-808A-8E18346D7EB4 Q30504549-E8557489-7759-4F54-A656-B05CF4530F25 Q30951324-33CD453A-5189-4D1F-BB18-D22DA76270DA Q31153960-6FF8E59E-AC8C-4C37-A1BE-D8CC6DD6787F Q33533645-2ABEE303-CE7E-4028-B34D-0DCF0711C30C Q33608271-E7A3C2C8-2A0F-4E23-9877-9F3B6CA5F0DB Q33649015-A38F637E-D895-4E11-BC07-06C18AE4F523 Q34038293-1BD6C249-210A-4375-B89D-DADDD5C89A1B Q34200524-0B5FD3A9-CDA6-427C-8405-CB02B81DDEA0 Q34234670-BFE8567A-E662-402C-BFD2-C2750A47661E Q34801745-D06E87EA-4033-4752-82EE-383FEACC3A59 Q34972657-B49DF95B-CEDD-4B08-84A6-8A5DC93251F9 Q35860992-5874C208-0659-4865-BB35-8C7C3930B46D Q36076000-6C1DF8E4-4E3D-43B1-A5F6-E0CB91BA24EA Q36275178-1908D75E-85BA-4EDD-95DC-52C09E097E01 Q36845978-9F6A442A-0028-42B7-ABC0-69921AB37A71 Q37002361-3DE85CFC-463D-453C-8EA8-11D59A23DE3A Q37198930-D024F2E5-F404-44DE-A4EC-AB03CCCEB366 Q38329673-E7C2C822-3846-4C7D-8BE0-1040A7AA164A Q38698051-1ACFACC0-3A9E-4AD5-83A5-474A87146364 Q38852157-F311BE66-0346-41AE-BFFC-D3A1E72886DA Q39512025-5CD926C4-0BA9-442B-9E1B-7E088FE3167C Q39815729-D1CF4E1A-571F-4A6B-B7EF-2EA6388BC4FA Q47135760-61723837-A310-47EB-8496-3B94F8808721 Q47230860-530667A8-8EDE-4E9E-8467-B90EB23CC4EF Q49307382-7C818090-B8AE-4B37-A842-382228518FDB Q54410902-73D14599-77E3-44C2-BCED-EE6CADF6F957 Q57119043-6879592A-E799-4139-BFE2-9A69099CE62E Q58327675-1189AD0A-3CF2-43C8-9555-FDB4B1B3E5E1

P2860

CRD-BP/IMP1 expression characterizes cord blood CD34+ stem cells and affects c-myc and IGF-II expression in MCF-7 cancer cells

http://www.wikidata.org/entity/Q28239956

description

2005 nî lūn-bûn

@nan

2005 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

CRD-BP/IMP1 expression charact ...... pression in MCF-7 cancer cells

@ast

CRD-BP/IMP1 expression charact ...... pression in MCF-7 cancer cells

@en

CRD-BP/IMP1 expression charact ...... pression in MCF-7 cancer cells

@nl

type

label

CRD-BP/IMP1 expression charact ...... pression in MCF-7 cancer cells

@ast

CRD-BP/IMP1 expression charact ...... pression in MCF-7 cancer cells

@en

CRD-BP/IMP1 expression charact ...... pression in MCF-7 cancer cells

@nl

prefLabel

CRD-BP/IMP1 expression charact ...... pression in MCF-7 cancer cells

@ast

CRD-BP/IMP1 expression charact ...... pression in MCF-7 cancer cells

@en

CRD-BP/IMP1 expression charact ...... pression in MCF-7 cancer cells

@nl

P1433

Q28239956-1CCA3C7B-1DEC-40B8-9B05-D79F3A3150B4

P1476

Q28239956-0EC24DF7-BE7A-4973-AAB3-7CDACD796A4B

P2093

Q28239956-286C8E8B-A947-48FD-BCE2-B17BDD17D0A7

Q28239956-3B2B12E2-CC56-4C9B-80B9-F2082D478002

Q28239956-4E54B17A-4CCF-4BA8-AFF6-527EF16CA20D

Q28239956-5147BDCC-8004-460B-905E-18D30FAAF116

Q28239956-7951BCF5-E004-4781-BD5C-B040B2AC9E9E

Q28239956-CE2ECA20-3F25-4644-B70A-AEF70324E6FD

Q28239956-EE7F8BF4-9CBD-4F9A-8817-CA0035355ADD

Q28239956-EF333C65-C1DC-4676-9FE3-145B57892918

Q28239956-F933B2D0-7B6C-4A0F-B3BE-1C8B97A7BB5A

P2860

Q28239956-08253EC0-286E-4FFC-9C57-AF3147AA5ADC

Q28239956-0C129315-B167-4B3C-8E8F-3F230BD7B0A1

Q28239956-18003FF0-D648-47F5-A9F1-1B245B98170D

Q28239956-1E988BA7-1935-4428-9A75-65DAA178B3EB

Q28239956-2844AABF-E969-443A-9128-67878B7EF740

Q28239956-2F366224-D52D-406F-BB02-6114420A26FE

Q28239956-316EBA1A-7FA8-4103-81B6-7C3E267BE031

Q28239956-4986E22C-9D86-4DD0-8B8F-02DBBEA8BEFE

Q28239956-5A3BFBDA-64DA-4567-9509-87BFCAEB4F45

Q28239956-61215025-8E31-47C9-81F5-509F289F1B72

P304

Q28239956-E314F205-BB47-4D04-9E2B-809613CE5E64

P31

Q28239956-9944948F-C4C5-4FF5-9598-DF3D235FCB3D

P356

Q28239956-065119D8-DAAF-43D7-9B2E-209C5A8DCABA

P407

Q28239956-4188007E-A6A7-4289-B493-81D558E134AB

P433

Q28239956-F33151FA-A882-47C1-BC91-9216D49B83CD

P478

Q28239956-8599BF98-70AA-4864-BE60-24CBA64419B1

P577

Q28239956-CF73BB5F-263F-483A-AC5D-D4592E175092

P698

Q28239956-D3941E65-738C-4ABF-85E6-12AC205F23E1

P356

P1433

Journal of Biological Chemistry

P1476

CRD-BP/IMP1 expression charact ...... pression in MCF-7 cancer cells

@en

P2093

Angelos D Gritzapis

http://www.w3.org/2001/XMLSchema#string

Aris I Antsaklis

http://www.w3.org/2001/XMLSchema#string

Constantin N Baxevanis

http://www.w3.org/2001/XMLSchema#string

Giannis J Kavalakis

http://www.w3.org/2001/XMLSchema#string

Louisa G Mahaira

http://www.w3.org/2001/XMLSchema#string

Michael Papamichail

http://www.w3.org/2001/XMLSchema#string

Panagiota A Sotiropoulou

http://www.w3.org/2001/XMLSchema#string

Panayotis Ioannidis

http://www.w3.org/2001/XMLSchema#string

Sonia A Perez

http://www.w3.org/2001/XMLSchema#string

P2860

A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development

Nuclear transit of human zipcode-binding protein IMP1

Dwarfism and impaired gut development in insulin-like growth factor II mRNA-binding protein 1-deficient mice

H19 RNA binds four molecules of insulin-like growth factor II mRNA-binding protein

8q24 Copy number gains and expression of the c-myc mRNA stabilizing protein CRD-BP in primary breast carcinomas

Targeted knockdown of the RNA-binding protein CRD-BP promotes cell proliferation via an insulin-like growth factor II-dependent pathway in human K562 leukemia cells

Control of c-myc mRNA half-life in vitro by a protein capable of binding to a coding region stability determinant

The role of DNA methylation in mammalian epigenetics

The insulin-like growth factor mRNA binding-protein IMP-1 and the Ras-regulatory protein G3BP associate with tau mRNA and HuD protein in differentiated P19 neuronal cells.

MYC oncogenes and human neoplastic disease.

P304

20086-93

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M410036200

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

280

http://www.w3.org/2001/XMLSchema#string

P577

2005-05-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15769738

http://www.w3.org/2001/XMLSchema#string